AWM
SLS icon

Axxcess Wealth Management’s SELLAS Life Sciences SLS Stock Holding History

Axxcess Wealth Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$611K Buy
41,373
+6,003
+17% +$41.4K 0.01% 660
2026
Q1 		$150K Hold
35,370
– – ﹤0.01% 368
2025
Q4 		$133K Buy
35,370
+19,370
+121% +$37.6K ﹤0.01% 1015
2025
Q3 		$25.8K Buy
+16,000
New +$28.5K ﹤0.01% 923

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Axxcess Wealth Management's SLS Position: Q2 2026 in Review

Axxcess Wealth Management increased its SELLAS Life Sciences (SLS) stake by 17% in Q2 2026, buying an estimated $41.4K and bringing the position to 41,373 shares worth $611K. The position accounts for 0.01% of the portfolio, ranked #660.

Axxcess Wealth Management first reported a position in SLS in Q3 2025 and has held it in 4 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Axxcess Wealth Management held 41,373 shares of SELLAS Life Sciences worth $611K as of Q2 2026.
  • Axxcess Wealth Management bought 6,003 SELLAS Life Sciences shares in Q2 2026, an estimated $41.4K.
  • SELLAS Life Sciences made up 0.01% of Axxcess Wealth Management's portfolio in Q2 2026, its #660 holding.
  • Axxcess Wealth Management first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Axxcess Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.